Systematic literature review and network meta‐analysis of sodium‐glucose co‐transporter inhibitors vs metformin as add‐on to insulin in type 1 diabetes
Author:
Affiliation:
1. Costello Medical Cambridge UK
2. University Hospital Llandough Cardiff UK
3. AstraZeneca Cambridge UK
Funder
AstraZeneca
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13863
Reference47 articles.
1. World Health Organization. Global report on diabetes.http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf. Accessed April 29 2019.
2. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth
3. Type 1 diabetes in adults: supporting self management
4. Health and Social Care Information Centre. National Diabetes Audit 2012–2013. Report 1: Care Processes and Treatment Targets.https://files.digital.nhs.uk/publicationimport/pub14xxx/pub14970/nati-diab-audi-12-13-care-proc-rep.pdf. Accessed July 15 2019.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy;Journal of Diabetes Science and Technology;2021-09-24
2. Efficacy and Cardiovascular Safety of SGLT2 Inhibitors;Current Drug Safety;2021-06-08
3. Demographic characteristics and acute complications among adults with type 1 diabetes: Comparison of two multicentre databases from Germany and the United States;Journal of Diabetes and its Complications;2021-03
4. Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis;Diabetes, Obesity and Metabolism;2021-01-06
5. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020);British Journal of Diabetes;2020-12-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3